ORKA Stock Price
Oruka Therapeutics, Inc.
ORKA stock price is $74.42 (+3.46% on the day), giving Oruka Therapeutics, Inc. a market cap of $4.76B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ORKA Stock Overview
- Price
- $74.42
- Previous close
- $71.93
- Open
- $72.40
- Market cap
- $4.76B
- P/E ratio
- -45.2
- 52-week range
- $25.11 - $115.52
- 1-year price target
- $145.21
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 39
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORKA | $74.42 | +3.5% | 223.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oruka Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW